Amsacrine: a new drug for hematological malignancies-Reference-Cited by-同舟云学术

Amsacrine: a new drug for hematological malignancies

Published:1985-01 Issue:1 Volume:21 Page:1-3
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

McCredie Kenneth B.

Publisher

Elsevier BV

Subject

Oncology

Reference9 articles.

1. The experimental antitumor properties of three congeners of the acridylmethanesulphonanilide (AMSA) series;Cain;Eur J Cancer,1974

2. Phase I clinical and pharmacological study of 4′-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) using an intermittent biweekly schedule;VanEcho;Cancer Res,1979

3. Phase II study of amsacrine gluconate in refractory leukemia;Omura;Cancer Treat Rep,1983

4. Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults;Legha;Blood,1982

5. Review of amsacrine, an investigational antineoplastic agent;Grove;Clin Pharmacokinet,1982

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly sensitive analysis of the anti-tumor agent 1-[4-(furo[2,3-b]-quinolin-4-ylamino)phenyl]ethanone in rat plasma by high-performance liquid chromatography using electrochemical detection;Journal of Pharmaceutical and Biomedical Analysis;2005-07

2. Amsacrine and Cisplatin in Poor Prognosis Patients with Metastatic Transitional Cell Carcinoma of the Urothelium: A Phase–II Study;European Urology;2001

3. Thermodynamic Studies of Amsacrine Antitumor Agents with Nucleic Acids;The Jerusalem Symposia on Quantum Chemistry and Biochemistry;1990

4. Potential antitumor agents. 52. Carbamate analogs of amsacrine with in vivo activity against multidrug-resistant P388 leukemia;Journal of Medicinal Chemistry;1987-09

5. Potential antitumor agents. 48. 3'-Dimethylamino derivatives of amsacrine: redox chemistry and in vivo solid tumor activity;Journal of Medicinal Chemistry;1987-04